Skip to main content

Table 3 Treatment of recurrence for patients after liver metastases resection

From: Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis

Characteristics

Before PSM (n = 240)

After PSM (n = 99)

Right-sided group (n = 54)

Left-sided group (n = 186)

P value

Right-sided group (n = 53)

Left-sided group (n = 46)

P value

Resection alone, n (%)

3 (5.6)

20 (10.7)

0.306

3 (5.7)

9 (19.6)

0.134

Ablation alone, n (%)

11 (20.4)

29 (15.6)

0.407

11 (20.8)

7 (15.2)

0.476

Chemotherapy alone, n (%)

27 (50.0)

70 (37.7)

0.103

18 (34.0)

17 (37.0)

0.756

Resection + chemotherapy, n (%)

3 (5.6)

9 (4.8)

0.735

3 (5.7)

2 (4.3)

1.000

Resection + radiotherapy, n (%)

1 (1.8)

3 (1.6)

0.905

1 (1.8)

0 (0.0)

NA

Ablation + chemotherapy, n (%)

3 (5.6)

25 (13.4)

0.149

3 (5.7)

2 (4.3)

1.000

Ablation + radiotherapy, n (%)

0 (0.0)

2 (1.1)

NA

0 (0.0)

0 (0.0)

NA

Radio + chemotherapy, n (%)

0 (0.0)

2 (1.1)

NA

0 (0.0)

0 (0.0)

NA

Supportive care, n (%)

6 (11.1)

26 (14.0)

0.585

14 (26.4)

9 (19.6)

0.421

  1. PSM propensity score matching